CD33 and Hyperglycemia: Preliminary studies in our research group demonstrated that oxidative stress induced by hyperglycemia decreases CD33 expression in human monocytes, but the pretreatment with the antioxidant α-tocopherol prevents ROS production and alteration in the CD33 expression.